Structure
atLeast majority ProS Experiment
:order disorder conflict PDB cluster ProS Pfam Domain SEG
239
order/disorder by at least rule
disorder by at least rule
order/disorder by majority rule
Seq 1-34,92-207 Monomer :
Region 4lvt A 1-8 disorder
Region 4lvt A 33-34 disorder
Region 4lvt A 92-204 order
Region 4lvt A 205-207 disorder
Seq 1-34,92-207 Hetero dimer : IID00720 Complex ,
IID00746 Complex
Region 5agw B 1-9 disorder
Region 5agw B 10-31 order
Region 5agw B 32-34 disorder
Region 5agw B 92-204 order
Region 5agw B 205-207 disorder
Seq 1-34,92-207 Monomer :
Region 4man A 1-7 disorder
Region 4man A 30-34 disorder
Region 4man A 92-204 order
Region 4man A 205-207 disorder
Seq 1-34,92-207 Hetero dimer : IID00720 Complex ,
IID00746 Complex
Region 5agx A 1-7 disorder
Region 5agx A 33-34 disorder
Region 5agx A 92-204 order
Region 5agx A 205-207 disorder
Seq 1-33,92-207 Homo hexamer : IID00720 Complex
Region 4aq3 F 1-8 disorder
Region 4aq3 F 33-33 disorder
Region 4aq3 F 92-203 order
Region 4aq3 F 204-207 disorder
Region 4aq3 E 1-9 disorder
Region 4aq3 E 10-32 order
Region 4aq3 E 33-33 disorder
Region 4aq3 E 92-203 order
Region 4aq3 E 204-207 disorder
Region 4aq3 D 1-8 disorder
Region 4aq3 D 32-33 disorder
Region 4aq3 D 92-203 order
Region 4aq3 D 204-207 disorder
Region 4aq3 C 1-8 disorder
Region 4aq3 C 32-33 disorder
Region 4aq3 C 92-203 order
Region 4aq3 C 204-207 disorder
Region 4aq3 B 1-8 disorder
Region 4aq3 B 32-33 disorder
Region 4aq3 B 92-203 order
Region 4aq3 B 204-207 disorder
Region 4aq3 A 1-8 disorder
Region 4aq3 A 32-33 disorder
Region 4aq3 A 92-203 order
Region 4aq3 A 204-207 disorder
Seq 1-34,92-207 Monomer :
Region 4lvt B 1-8 disorder
Region 4lvt B 33-34 disorder
Region 4lvt B 92-204 order
Region 4lvt B 205-207 disorder
Seq 1-34,92-207 Hetero dimer : IID00720 Complex ,
IID00746 Complex
Region 5agx B 1-7 disorder
Region 5agx B 33-34 disorder
Region 5agx B 92-204 order
Region 5agx B 205-207 disorder
Seq 1-34,54-60,92-207 Hetero dimer : Q99HR6
Region 5fcg A 1-5 disorder
Region 5fcg A 54-60 disorder
Region 5fcg A 92-203 order
Region 5fcg A 204-207 disorder
Seq 1-34,92-207 Monomer :
Region 4lxd A 1-5 disorder
Region 4lxd A 34-34 disorder
Region 4lxd A 92-204 order
Region 4lxd A 205-207 disorder
Seq 1-34,92-207 Monomer :
Region 4man B 1-7 disorder
Region 4man B 30-34 disorder
Region 4man B 92-204 order
Region 4man B 205-207 disorder
Seq 1-34,92-207 Monomer :
Region 1gjh A 1-2 disorder
Region 1gjh A 92-207 order
Seq 1-34,92-207 Hetero dimer : IID00720 Complex ,
IID00746 Complex
Region 5agw A 1-7 disorder
Region 5agw A 32-34 disorder
Region 5agw A 92-204 order
Region 5agw A 205-207 disorder
Seq 1-34,92-207 Monomer : IID00720 Complex
Region 4ieh A 1-8 disorder
Region 4ieh A 32-34 disorder
Region 4ieh A 92-204 order
Region 4ieh A 205-207 disorder
Seq 1-34,92-207 Monomer :
Region 1g5m A 1-2 disorder
Region 1g5m A 92-207 order
Seq 1-207 Hetero dimer : Q07813
Region 2xa0 B 1-9 disorder
Region 2xa0 B 10-31 order
Region 2xa0 B 32-91 disorder
Region 2xa0 B 92-206 order
Region 2xa0 B 207-207 disorder
Region 2xa0 A 1-9 disorder
Region 2xa0 A 10-31 order
Region 2xa0 A 32-91 disorder
Region 2xa0 A 92-206 order
Region 2xa0 A 207-207 disorder
Region 5jsn C 1-6 disorder
Region 5jsn C 33-86 disorder
Region 5jsn C 87-207 order
Region 5jsn A 1-6 disorder
Region 5jsn A 33-86 disorder
Region 5jsn A 87-207 order
Seq 3-33,92-206 Monomer :
Region 1ysw A 92-206 order
Seq 3-34,92-207 Monomer :
Region 2o21 A 92-207 order
Seq 3-34,92-207 Monomer :
Region 2o22 A 92-207 order
Seq 8-31,92-204 Monomer :
Region 2o2f A 92-204 order
Region 2w3l B 92-204 order
Region 2w3l B 205-206 disorder
Region 2w3l A 92-206 order
70-70 Phosphoserine; by MAPK8 and PKC
87-87 Phosphoserine; by MAPK8
69-69 Phosphothreonine; by MAPK8
Prediction
Disorder 1-9,36-90,237-239
ProS 1-9,53-58,64-70,237-239
Disorder 1-7,33-85,204-239
SEG 31-47
,75-93
,213-225
Function
Function in SwissProt
Suppresses apoptosis in a variety of cell systems including factor-dependent lymphohematopoietic and neural cells. Regulates cell death by controlling the mitochondrial membrane permeability. Appears to function in a feedback loop system with caspases. Inhibits caspase activity either by preventing the release of cytochrome c from the mitochondria and/or by binding to the apoptosis-activating factor (APAF-1). May attenuate inflammation by impairing NLRP1-inflammasome activation, hence CASP1 activation and IL1B release (PubMed:17418785).